Prevalence of neonatal jaundice at a tertiary health institution in Ondo state, Nigeria
More details
Hide details
Bowen University Iwo, Nigeria
Ondo State School of Midwifery, Akure, Nigeria
Federal Medical Centre, Nigeria
University of Medical Sciences, Ondo, Nigeria
Department of Nursing Science, University of Medical Sciences, Ondo, Nigeria
Matthew Idowu Olatubi   

Bowen University Iwo, Ikire road Iwo, 251105, Iwo, Nigeria
This study assesses the occurrence of neonatal jaundice among neonates admitted between January 2007 – December 2016 in a tertiary health institution in Ondo State, Nigeria.

Materials and method:
A descriptive retrospective research design was used for the study conducted in the Neonatal Ward of a tertiary health institution in Ondo State. Data were collected using a self-structurd checklist. Ethical clearance was obtained from the hospital Ethical Committee. Data was analyzed using SPSS; both descriptive and inferential statistics were used.

Results showed that a total of 715 neonates were admitted in the hospital during the period, 88 (34.2%) were admitted on their first day of birth. There were more male neonates admitted for jaundice than female 146 (56.8%). The highest incidence of neonatal jaundice in the hospital during the years under review occurred in 2008 (32 neonates); while the least was recorded in 2016 – 9 neonates. A total of 257 neonates were admitted for neonatal jaundice over the 10 year period under review. The serum bilirubin level reduced from 13.76±8.04 on admission to 3.43±2.34 at discharge. Only 61 (23.7%) of the neonates had exchange blood transfusion performed. Also, 36 (14.0%) neonates developed complications of neonatal jaundice, of which 25 (69.4%) died from these complications

A concerted effort should be made to create awareness about neonatal jaundice among women of reproductive age, and emphasis should be placed on the importance of early diagnosis and treatment of NNJ.

Sarici SU, Serdar MA, Korkmz A. Incidence, course and prediction of hyperbilirubinaemia in near term and term newborns. Paediatrics. 2004; 113: 775–780.
Newman TB, Xiong B, Gonzales VM, Escobar GJ. Prediction and prevention of extreme neonatal hyperbilirubinemia in a mature health maintenance organization. Arch Pediat Adolescent Med. 2000; 154: 1140–1147.
Watchko JF. Identification of neonates at risk for hazardous hyperbilirubinemia: emerging clinical insights. Pediatric Clin North Am. 2009; 56: 671–687.
Liu X, Wang L, Stallones L, Wheeler KK, ZhaoW, Smith GA, Xiang H. Back pain among farmers in a northern area of China. Spine 2012; 37: 508–514.
Maisels MJ. Neonatal hyperbilirubinemia and kernicterus—not gone but sometimes forgotten. Early Hum Dev. 2009; 85(11): 727–732. doi: 10.1016/j.earlhumdev.2009.09.003 PMID: 19833460.
Olusanya BO, Akande AA, Emokpae A, Olowe SA. Infants with severeneonatal jaundice in Lagos, Nigeria: incidence, correlates and hearingscreening outcomes. Trop Med Int Health. 2009; 14(3): 301–310.
Hameed NN, Na’ Ma AM, Vilms R, Bhutani VK. Severe neonatal hyperbilirubinemia and adverseshort-term consequences in Baghdad, Iraq. Neonatology 2011; 100: 57–63. doi: 10.1159/000321990 PMID:21212697.
Sgro M, Campbell D, Barozzino T & Shah V. Acute neurological findings in a national cohort of neonates with severe neonatal hyperbilirubinemia. J Perinat. 2011; 31: 392–396.
Bhutani VK, Zipursky A, Blencowe H, Khanna R, Sgro M, et al. Neonatal hyperbilirubinemia andRhesus disease of the newborn: incidence and impairment estimates for 2010 at regional and globallevels. Pediatr Res. 2013; 74 Suppl 1: 86–100. doi: 10.1038/pr.2013.208 PMID: 24366465.
Scrafford CG, Mullany LC, Katz J, Khatry SK, LeClerq SC, Darmstadt GL, Tielsch JM. Incidence of and risk factors for neonatal jaundice among newborns in southern Nepal. Trop Med Int Health. 2013; 18(11): 1317–28. doi: 10.1111/tmi.12189.
Slusher TM, Zamora TG, Appiah D, Stanke JU, Strand M, et al. Global burden of severe neonatalhyperbilirubinemia: a systematic review and meta-analysis. JAMA Pediatrics (under review). 2014. doi:10.1001/ jamapediatrics.2014.2898 PMID: 25546699.
Owa JA, Ogunlesi TA. Why we are still doing so many exchange blood transfusion for neonatal jaundice in Nigeria. World J Pediatr. 2009; 5: 51–55.
Onyearugha CN, Onyire BN, Ugboma HAA. Neonatal jaundice: Prevalence and associated factors as seen in Federal Medical Centre Abakaliki, Southeast Nigeria. J Clin Med Res. 2011; 3(3): 40–45. Available online http://www.academicjournals.or....
Coulter JBS, Akpabio MA, Jikeme MA, Kay T. Neonatal Jaundice in Northern Nigeria. Nig J Paediatr. 1978; 5: 12–5.
Abu-Ekteish F, Daoud A, Rimawi H, Kakish K, Abu-Heija A. Neonatal exchangetransfusion: a Jordanian experience. Ann Trop Paediatr. 2000; 20(1): 57–60.
Jirapaet K. Thai healthy newborns have a higher risk. J Med Assoc Thai. 2005; 88(9): 1314–1318.
Ogunlesi TA, Dedeke IO, Adekanmbi AF, Fetuga MB, Ogunfowora OB. The incidence and outcome of bilirubin encephalopathy in Nigeria: abi-centre study. Niger J Med. 2007; 16(4): 354–359.
Salas AA, Mazzi E. Exchange transfusion in infants with extreme hyper bilirubinemia: an experience from a developing country. Acta Paediatr. 2008; 97(6): 754–758.
Sanpavat S. Exchange transfusion and its morbidity in ten-year period at King Chulalongkorn Hospital. J Med Assoc Thai. 2005; 88(5): 588–592.
Tikmani SS, Warraich HJ, Abbasi F, Rizvi A, Darmstadt GL, Zaidi AK. Incidence of neonatal hyperbilirubinemia: a population-based prospective study in Pakistan. Trop Med Int Health. 2010; 15(5): 502– 507.
Olusanya BO. Letter to the editors: the burden of neonatal jaundice and sepsis in developing countries. Trop Med Int Health 2006; 11(3): 381.
Slusher T, Zipursky A, Bhutani VK. A global need for affordable neonatal jaundice technologies. Semin Perinatol. 2011; 35(3): 185–191.
Iskander I, Gamaleldin R, El Houchi S, El Shenawy A, Seoud I, El Gharbawi N, et al. Serum bilirubin and bilirubin/albumin ratio as predictors of bilirubin encephalopathy. Pediatrics 2014; 134: e1330-e1339.